The NIH Clinical Trial Integrity Act aims to enhance the diversity of participants in clinical trials funded by the National Institutes of Health (NIH). By ensuring that clinical trials reflect the demographics of the populations affected by the medical conditions under study, the Act seeks to improve the accuracy and effectiveness of medical treatments for all groups. To achieve this, the Act requires NIH-funded research organizations to establish specific goals for recruiting and retaining participants from various racial, ethnic, age, and gender backgrounds.